12:00 AM
 | 
Apr 06, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ThermoDox heat-activated liposome: Phase I data

Data from a Phase I trial in 24 patients showed that the median time to treatment failure was 374 days in patients who received radiofrequency ablation (RFA) and >=50 mg/m 2 IV ThermoDox, which is the previously...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >